| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.04 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |